OBJECTIVE To provide an evidence-based overview of drug treatment for long-term
secondary prevention of myocardial infarction (MI). DATA SOURCES We conducted …

Objectives: Clinical trials have demonstrated that secondary prevention of myocardial
infarction is effective, but several studies have suggested that research findings are not …

Acute myocardial infarction (MI) is the leading cause of death around the globe. Advances in
the field of cardiology have identified several effective treatments that have lead to decrease …

Therapeutic research into secondary prevention after myocardial infarction has a
disappointing cost-benefit record. Many unrecognised biological problems have …

Secondary prevention following acute myocardial infarction begins at the time of the in initial
hospitalization. An aggressive approach should focus on appropriate lifestyle changes as …

~ espite significant improvement in primary prevention and management, acute myocardial
infarction remains a major public health problem in the United States and most industrial …

BACKGROUND:: Myocardial infarction (MI) is a common cause of death in developed
countries. Long-term preventive pharmacotherapy has been shown to decrease mortality …

Secondary prevention of MI generally means prevention of cardiovascular accidents in post-
MI patients. Cardiac accidents denote cardiac death (ie, fatal MI, sudden cardiac death, and …

The high risk of subsequent mortality and morbidity following the occurrence of a myocardial
infarction (MI) underlies the importance of instituting effective preventive regimens as part of …

The efficacy of combining antiplatelet agents with low doses of aspirin to prevent cardiac
events in patients with myocardial infarction was examined. A total of 1,083 patients with …